Clinical Trial Update: Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating whether combining SBRT and immunotherapy can induce abscopal effects in advanced non-small cell lung cancer (stage IV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Non-Small-Cell Lung Cancer Stage IV | Phase 2 | Status: COMPLETED